Until it is actually launched, there is zero benefit to Elite since there can be no comparison study, per Nasrat's plan. Looking forward to the next update.
Date Article Aug 19, 2016 Approval FDA Approves Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) Capsules with Abuse-Deterrent Properties for the Management of Pain Jun 8, 2016 Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules for Approval Feb 13, 2015 Pfizer Announces FDA Acceptance for Review of NDA for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)